This report discusses US biologicals demand for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, technological and product development, regulatory considerations, market environment, product and market forecasts, industry composition and leading participants. Product segments include recombinant proteins, monoclonal antibodies (Mabs), vaccines, blood and blood derivatives, and other biologicals; market segments cover pharmacy, ambulatory health care, hospital, other health care markets, and other markets. This 20 page report also includes a highlights summary and a resources section.
(0 items)
